Literature DB >> 8474533

Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins.

E Glusa1, E Müller-Schweinitzer.   

Abstract

Changes in tension were monitored isometrically on helical strips from both femoral and saphenous human veins obtained during autopsy and during surgical removal of varicose veins respectively. Both venous tissues contracted in response to 5-hydroxytryptamine (5-HT), 5-carboxamidotryptamine (5-CT) and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). While 5-HT was about 2 times more potent in saphenous (pD2 = 7.35) than in femoral veins (pD2 = 7.04), 5-CT stimulated the saphenous vein (pD2 = 7.62) at about 20 times lower concentrations than were required for stimulation of the femoral vein (pD2 = 6.27). 8-OH-DPAT induced venoconstriction only when used at very high concentrations and pD2 values could not be determined. These data suggested different subtypes and/or distribution of 5-HT receptors in both venous preparations. Further evidence for this was obtained by the observation that spiperone (a 5-HT receptor blocker with high affinity for 5-HT2 and 5-HT1A sites) produced a parallel shift to the right of the 5-HT curve in femoral veins but elicited a biphasic displacement of the 5-HT curve in saphenous veins. In the femoral vein, spiperone showed a pA2 value of 9.20 +/- 0.08, statistically not different from that calculated for the spiperone sensitive 5-HT effect in saphenous vein (pA2 = 9.14 +/- 0.08). The results suggest that regional variations in the distribution of 5-HT receptor subtypes do exist, human femoral veins possessing mainly 5-HT2 receptors whereas in human saphenous veins both 5-HT1-like and 5-HT2 receptors are present.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474533     DOI: 10.1007/bf00169257

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  An examination of 5-hydroxytryptamine receptors in human saphenous vein.

Authors:  J R Docherty; L Hyland
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

2.  Comparison of the actions of serotoninergic agents on human saphenous veins and platelets.

Authors:  M Victorzon; C Tapparelli; E Müller-Schweinitzer
Journal:  Eur J Pharmacol       Date:  1986-05-13       Impact factor: 4.432

3.  Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

Authors:  P B Bradley; G Engel; W Feniuk; J R Fozard; P P Humphrey; D N Middlemiss; E J Mylecharane; B P Richardson; P R Saxena
Journal:  Neuropharmacology       Date:  1986-06       Impact factor: 5.250

4.  5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins.

Authors:  W A Bax; D Van Heuven-Nolsen; E Bos; M L Simoons; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

5.  Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

6.  Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.

Authors:  E Glusa; F Markwardt
Journal:  Pharmacology       Date:  1984       Impact factor: 2.547

7.  Adrenergic and serotoninergic mechanisms in human hand arteries and veins studied by fluorescence histochemistry and in vitro pharmacology.

Authors:  B Arneklo-Nobin; C Owman
Journal:  Blood Vessels       Date:  1985

8.  Serotonergic mechanisms in isolated human peripheral arteries and veins.

Authors:  B Arneklo-Nobin; A Nobin; C Owman; K Törnebrandt
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

9.  Effects of 5-hydroxytryptamine on human isolated placental chorionic arteries and veins.

Authors:  J Reviriego; J Marín
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

10.  Contractile effects of noradrenaline and 5-hydroxytryptamine in human hand veins: a pharmacological receptor characterization.

Authors:  M Arner; E D Högestätt
Journal:  Acta Physiol Scand       Date:  1986-10
  10 in total
  4 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.

Authors:  J P Valentin; R Bonnafous; G W John
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.

Authors:  Y Nishimura
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptors.

Authors:  H Pertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.